Status:
RECRUITING
Renal Nerve Stimulation in Uncontrolled Hypertensive Patients Undergoing Renal Denervation
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Hypertension
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
Study design: Investigator initiated, single center The study is aimed 1\) To investigate the blood pressure (BP) change to renal nerve stimulation(RNS), and subsequently perform a renal denervation(...
Detailed Description
Hypertension has become a global public health concern and associated with considerable risk of cardiovascular, cerebrovascular and kidney diseases. Although pharmacological blood pressure (BP) contro...
Eligibility Criteria
Inclusion
- Patients with hypertension (HTN), including
- 24-hour ambulatory blood pressure \>130/ 80 mmHg
- Age 20-80 years
- Glomerular filtration rate \>45 mL/min
Exclusion
- Unsuitable renal artery anatomy computed tomographic angiography (main renal artery lumen diameter ≤3 mm or a total length \<20 mm of the main arteries).
- untreated secondary HTN, including hyperaldosteronism, pheochromocytoma, renal artery stenosis(\>50% stenosis)
Key Trial Info
Start Date :
June 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05421767
Start Date
June 24 2022
End Date
December 31 2027
Last Update
June 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100